In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days
Clinical trial NCT04022889 · COMPLETED
Trial details
- NCT number
- NCT04022889
- Sponsor
- Cerus Corporation
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-05
- Primary completion
- 2021-04-16
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.